Biotech / MedTech
Temasek led $208M equity investment in German radiopharmaceutical biotech firm ITM
Singapore state-owned investor Temasek has led EUR 188 million ($208 million) equity investment in German radiopharmaceutical biotech firm ITM Isotope Technologies Munich SE (ITM).
Singapore’s Allozymes raises $15M in Series A funding led by Seventure Partners, Xora Innovation
Allozymes, a Singapore-based innovator in enzyme discovery and engineering, has on Monday announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singapore.
Singapore’s NSG BioLabs raises $14.5M in financing round led by Celadon Partners
NSG BioLabs, Singapore's largest provider of biotech co-working laboratory and office space, has successfully concluded a $14.5 million financing round. The round was led by Celadon Partners, an Asian private equity firm.
From lab to cure: Three trailblazing trends for biotech startups in 2024
As we peer into the future of the APAC biotech landscape, biotech startups will continue to see opportunities for innovation and funding on the horizon. The anticipated trends in strategic investments, government support, and collaborative efforts suggest that 2024 will be a pivotal year for aspiring biotech entrepreneurs. Success in this dynamic landscape…
South Korea’s S&S Lab partners Singapore’s FVC to support biotech and foodtech startups
South Korea’s private sector-led shared research lab S&S Lab (the operator of IRIS Lab) has announced its latest strategic partnership with Singapore innovation ecosystem enabler Farquhar VC (FVC), to foster and deepen relations among Korean and global novel food and biotech startups.
Indonesian biotechnology startup Moosa Genetics raises new funding led by East Ventures
Moosa Genetics, an animal genomics and biotechnology startup based in Indonesia, has on Monday announced that the company raised funding led by East Ventures, a venture capital firm focusing on Southeast Asia. The funding also saw the participation from angel investors.
Automera secures $16M in Series A funding co-led by ALSP, ClavystBio
Automera, a new biotechnology company based in Singapore, has secured $16 million in Series A funding co-led by Accelerator Life Science Partners (ALSP) and ClavystBio. The funding also saw participation from Singapore-based global investor EDBI, Xora Innovation, and other undisclosed investors.
InnovaTalk Webinar recap: Understanding medication-gut microbiome interactions
The July InnovaTalk Webinar hosted by the VinFuture Foundation highlighted the most recent research endeavors in understanding the interaction between medication drugs and the human gut microbiome, their implications on various complications including Antimicrobial Resistance and malnutrition, and challenges and opportunities to expand microbiome research…
Hong Kong’s Immuno Cure completes $12M first close of Series A financing led by Gobi Partners
Hong Kong-based biotech firm Immuno Cure BioTech (Immuno Cure) announced Thursday that it has closed the $12 million tranche in the $27 million Series A fundraising round. Led by the AEF Greater Bay Area Fund that Gobi Partners GBA (Gobi GBA) manages, this round will be used to accelerate the development of DNA vaccines and antibodies, as well as to prepare…
500 Global-backed Thai food biotech firm IncreBio to launch products in Singapore by year-end
The company has raised over $2 million from 500 Global, TOP Ventures (CVC-arm of Thai Oil PLC) and angel investors—from a group of former executives of Coca-Cola, PepsiCo and Dole, to a family office of one of the largest healthcare networks in Southeast Asia.
